Study ID: COG AAML1531
Risk-stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
A COG Groupwide Phase III Study
Fargo Region, Sioux Falls Region
Kayelyn Wagner, MD,Samuel Anim, MD
AML (Acute Myelogenic Leukemia)
Active - Open to Accrual
For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.